Jmac Enterprises LLC
- SEC CIK
- 0001907294
- Latest filing
- Jul 28, 2026
BCLI holding history
Brainstorm Cell Therapeutics Inc. in every 13F filed by Jmac Enterprises LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCLI overviewAll 13F holders of BCLIFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −4,362−100.0% | Sold outConverted for a 1-for-15 split | Holders |
| Q3 2024 | 65,430 | $15.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 65,430 | $22.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 65,430 | $36.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 65,430 | $17.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 65,430 | $13.1K | <0.1% | +25,000+61.8% | Added | Holders |
| Q2 2023 | 40,430 | $83.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 40,430 | $133.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 40,430 | $66.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 40,430 | $179.0K | 0.1% | −5,000−11.0% | Reduced | Holders |
| Q2 2022 | 45,430 | $125.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 45,430 | $153.0K | <0.1% | +45,430 | New | Holders |